These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2404713)

  • 1. Immunoscintigraphy of colorectal cancer with an antibody to epithelial membrane antigen (EMA).
    Yiu CY; Baker LA; Davidson BR; Ward M; Roberts K; Clarke G; Ward C; Westwood J; Boulos PB; Clark CG
    Dis Colon Rectum; 1990 Feb; 33(2):122-6. PubMed ID: 2404713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-epithelial membrane antigen monoclonal antibodies and radioimmunolocalization of colorectal cancer.
    Yiu CY; Baker LA; Boulos PB
    Br J Surg; 1991 Oct; 78(10):1212-5. PubMed ID: 1958987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative imaging of colorectal cancers. Targeting the epithelial membrane antigen with a radiation-labeled monoclonal antibody.
    Davidson BR; Young H; Waddington WA; Babich J; Clarke GA; Short MD; Boulos PB; Styles J; Dean C; Ell PJ
    Cancer; 1992 Feb; 69(3):620-5. PubMed ID: 1730114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoscintigraphy of colorectal cancer using a monoclonal antibody 77-1.
    Yiu CY; Baker LA; Davidson BR; McCready VR; Boulos PB
    Eur J Surg Oncol; 1991 Oct; 17(5):495-501. PubMed ID: 1936297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
    Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
    Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
    Welt S; Divgi CR; Scott AM; Garin-Chesa P; Finn RD; Graham M; Carswell EA; Cohen A; Larson SM; Old LJ
    J Clin Oncol; 1994 Jun; 12(6):1193-203. PubMed ID: 8201382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoscintigraphy of colorectal cancer with 111In labeled anti-CEA monoclonal antibody (ZCE-025)].
    Katayama M; Nakamura K; Hashimoto T; Tsukatani Y; Fujii H; Hashimoto J; Kubo A; Hashimoto S; Teramoto T; Kodaira S
    Kaku Igaku; 1991 Sep; 28(9):1057-65. PubMed ID: 1770658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoscintigraphy with monoclonal antibody Tc99m BW 431/26 in the diagnosis of colorectal carcinoma].
    Muxí A; Bassa P; Moragas M; Fernández R; Pons F; Setoaín J
    Med Clin (Barc); 1991 Mar; 96(8):287-91. PubMed ID: 2041400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoscintigraphy with a new indium-111-labeled monoclonal antibody (MAb 1A3) in patients with colorectal cancer.
    Philpott GW; Siegel BA; Schwarz SW; Connett JM; Rocque PA; Fleshman JW; Wallis JW; Baumann M; Sun Y; Martell AE
    Dis Colon Rectum; 1994 Aug; 37(8):782-92. PubMed ID: 8055723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate.
    Chetanneau A; Barbet J; Peltier P; Le Doussal JM; Gruaz-Guyon A; Bernard AM; Resche I; Rouvier E; Bourguet P; Delaage M
    Nucl Med Commun; 1994 Dec; 15(12):972-80. PubMed ID: 7715897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunolocalisation of an anti-EMA monoclonal antibody to a renal carcinoma xenograft.
    Yiu CY; Baker LA; Boulos PB
    Anticancer Res; 1990; 10(6):1775-8. PubMed ID: 2285258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
    Barbet J; Peltier P; Bardet S; Vuillez JP; Bachelot I; Denet S; Olivier P; Leccia F; Corcuff B; Huglo D; Proye C; Rouvier E; Meyer P; Chatal JF
    J Nucl Med; 1998 Jul; 39(7):1172-8. PubMed ID: 9669389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
    Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmune localization of occult carcinoma.
    Duda RB; Zimmer AM; Rosen ST; Gilyon KA; Webber D; Spies S; Spies W; Merchant B
    Arch Surg; 1990 Jul; 125(7):866-70. PubMed ID: 2369311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
    Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
    J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does immunoscintigraphy improve early diagnosis of metastatic or recurrent cancer?].
    Hölting T; Steinbächer M; Kretzschmar U; Georgi P; Schlag P
    Onkologie; 1989 Aug; 12 Suppl 1():20-5. PubMed ID: 2685691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
    Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
    Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast tumor radioimmunodetection with a 111In-labeled monoclonal antibody (MA5) against a mucin-like antigen.
    Major PP; Dion AS; Williams CJ; Mattes MJ; Wang T; Rosenthall L
    Cancer Res; 1990 Feb; 50(3 Suppl):927s-931s. PubMed ID: 2297743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.